| Clinical data | |
|---|---|
| Trade names | Bromylene, Eitriphin, Oestronyl, Prostilban, Tribenorm |
| Identifiers | |
|
|
| Synonyms | Bromotriphenylethylene; Phenylstilbene bromide; Fenbrostilbenum |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C20H15Br |
| Molar mass | 335.244 g/mol |
| 3D model (JSmol) | |
|
|
|
|
Triphenylbromoethylene (brand names Bromylene, Eitriphin, Oestronyl, Prostilban, Tribenorm), also known as bromotriphenylethylene or as phenylstilbene bromide, is a synthetic, nonsteroidal estrogen of the triphenylethylene group that was marketed in the 1940s similarly to the closely related estrogen triphenylchloroethylene.
A diethoxylated derivative of triphenylbromoethylene, estrobin (DBE), is also an estrogen, but, in contrast, was never marketed. An ethylated derivative of triphenylbromoethylene, broparestrol (BDPE), is a selective estrogen receptor modulator (SERM) that has been marketed.